Sol-Gel Technologies, Ltd. IPO Research Information

Sol-Gel Technologies, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Sol-Gel Technologies, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Sol-Gel Technologies, Ltd.	SLGL - NASDAQ	$11.00-$13.00	$12.00	$15.33	6.25 million	2/1/2018
Underwriter(s): Jefferies, BMO Capital Markets
Co-Manager(s): JMP Securities, Raymond James
Industry: Health Care
Filing(s): Filed 2017-08-29 Terms Added 2018-01-23 Final Prospectus 2018-02-02

Sol-Gel Technologies, Ltd. Quote & Chart - Click for current quote - SLGL

About Sol-Gel Technologies, Ltd. (adapted from Sol-Gel Technologies, Ltd. prospectus):
They are a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SLGL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.